Dengue seroprevalence in Golfito and the central district of Puntarenas, Costa Rica 2005-2006

Authors

  • Margarita Lee Lui Universidad de Costa Rica
  • Jonathan Alfaro Alvarado Universidad de Costa Rica
  • Aryam Quesada Johnson Universidad de Costa Rica
  • Lizeth Taylor Castillo Universidad de Costa Rica
  • Laya Hun Opfer Universidad de Costa Rica

DOI:

https://doi.org/10.51481/amc.v50i3.378

Keywords:

dengue fever, dengue hemorrhagic fever, seroprevalence, dengue shock syndrome, epidemiology, vector Aedes aegypti

Abstract

Justification and objectives: Dengue infection could be asymptomatic or it can produce a mild acute febrile illness, dengue fever, or a severe illness, such as hemorrhagic dengue or shock syndrome (DHF/SSD). Illness severity depends upon various risk factors like viral characteristics, infestation of the vector as well as host factors; presence of more than 1 dengue virus serotype and secondary infections. Since 1993 when the first cases of dengue were reported in Costa Rica Puntarenas's First District population has been 1 of the most affected areas, although there has been a decline in the incidence over the last years. The Brunca Region was the second with high incidence of dengue in 1998 and since then cases have been reported permanently. The national incidence is based on the clinical cases weekly report by the Ministry of Health, but there are no seroepidemyological studies to determine the seroprevalence of the disease. Determining IgG antibodies prevalence against dengue at the First Puntarenas's District and at Golfito district will allow us to better understand the incidence and calculate the percentage of the population at risk of developing DHF/SSD associated with the epidemiological data.
Methods: For the seroprevalence study we collected 210 sera samples from each region and used an IgG capture ELISA developed and standardized in our laboratory using as reference the Dulbecco Plaque Method. Samples were obtained utilizing the EPI method (Expanded Program on Immunization) described by the World health Organization (WHO).
Results: The study showed 43.8% (92) and 90% (189) prevalence in the districts of Golfito and Puntarenas respectively, no significant differences in gender, age and geographical location were found. We determined an 83% in Golfito and a 95% in Puntarenas correlation between serology and symptomatic cases and 42% from total seropositive people in each region denied having clinical symptoms. Since this is a representative sample study we can affirm that a similar percentage of asymptomatic cases occur in the general population.
Conclusions: Seropositivity against dengue virus in the First Puntarenas's District population is very high (90%) and although the Golfito District has been reported with a low prevalence since 1998, this study shows that near 50% of the population is seropositive with the consequent risk for DHF/SSD. It is very important to continue this type of seroepidemiological studies in other regions of the country to verify the real threat of this disease in order to take the necessary preventive measures.

Downloads

Download data is not yet available.

References

Gubler DJ. Dengue and Dengue Hemorrhagic Fever. Clin Microbiol 1998; 11:480-496.

Lanciotti R, Calisher C, Gubler D, Chang G, Vorndam V. Rapid detection and typing of dengue viruses from clinical samples by using Reverse Transcriptase Polymerase Chain Reaction. J. Clin Microbiol 1992; 545-554.

Rico-Hesse R, Harrisosn LM, Salas RA, Tovar D, Nisalak A, Ramos C. et al. Origins of dengue type 2 associated with increased pathogenicity in the Americas. Virology 1997; 230:244-251.

Clyde K, Kyle JL, Harris E. Recent Advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 2006; 80:11418-11431.

Guzman MG, Kouri GH. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003; 27:1-13.

Kochel TJ, Watts DM, Gozalo AS, Ewing DF, Porter KR, Russell KL.Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J Infect Dis 2005; 15: 1000-1004.

Carrington C, Foster J, Pybus O, Bennet S, Holmes E. Invasion and maintenance of dengue virus type 2 and type 4 in the Americas. J. Virol 2005; 79:14680-14687.

Anderson J, Rico- Hesse R. Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus. Am J Trop Med Hyg 2006; 75:886-892.

Ministerio de Salud, Caja Costarricense de Seguro Social y Organización Panamericana de la Salud Informe Final ""Estrategia Nacional de Gestión Integrada de Prevención y Control del Dengue en Costa Rica"" periodo 28 de noviembre al 1 de diciembre de 2004.

World Health Organization. Outbreak of classic dengue, Costa Rica. Wkly Epidemiol Rec. 1994; 69:85-86.Ministerio de Salud Pública de Costa Rica. Comisión Técnica Interinstitucional. Normas técnicas para el control del dengue y dengue hemorrágico. Costa Rica 2000.

Ministerio de Salud de Costa Rica. Análisis Sectorial de Salud: Componente Demográfico epidemiológico. 2006.

Iturrino-Monge R, Avila-Agüero ML, Avila-Agüero CR, Moya-Moya T, Cañas-Coto A, Camacho-Badilla K, Zambrano-Mora B. Seroprevalence of dengue virus antibodies in asymptomatic Costa Rican children, 2002-2003: a pilot study. Rev Panam Salud Pública. 2006; 20:39-43.

Ministerio de Salud de Costa Rica. Boletines estadísticos de enfermedades de declaración obligatoria. 1999-2007.

Kliks S, Nisalak A, Brandt W, Wahl L, Burke D. Antibody -Dependent enhancement of dengue virus growth in human monocites as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989; 440:444-451.

Halstead SB. Observations related to pathogenesis of dengue hemorrhagic fever. VI. J Biol Med 1970; 42:350-362.

Sáenz E, Maranda L,Piza J, González L, Achoy R. Evaluación del sistema de vigilancia epidemiológico del dengue utilizando como indicador la aplicación de la definición de caso sospechoso, Costa Rica 1998. Rev Costarric Cienc Méd 2001; 22:117.129.

Hoshaw S. Description and comparison of the methods of cluster sampling and lot quality assurance sampling to assess immunization coverage. Department of vaccine and biological, World Health Organization, Geneva. 2001.

Rusell PK, Nisalak A, Sukhavachana P, Vivona S. A plate reducction test for dengue virus neutralizing antibodies. J Immunol 1967; 99: 285-290.

Lee M. Estudio seroepidemiológico de dengue en el distrito de Golfito, Costa Rica, en el año 2005. Trabajo de Graduación para optar por el grado de licenciatura en Microbiología y Química Clínica. Junio. 2006.

Ávalos A. Salud detecta nuevo tipo de dengue en la frontera sur. La Nación; 25 de enero 2008.

Kourí G, Guzmán MG, Valdés L, Carbonel I, del Rosario D, Vázquez S, Laferté J, Delgado J, Cabrera MV. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis 1998; 4:89-92.

Álvarez M, Rodríguez-Roche R, Bernardo L, Vázquez S, Morier L, González D, Castro O, Kouri G, Halstead SB, Guzmán MG. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infection over a long time interval: Havana Epidemic, 2001-2002. Am J Trop Med Hyg 2006; 75:1113-7.

Navarrete J, Acevedo J, Huerta E, Torres J, Gavaldón, D. Prevalencia de anticuerpos contra dengue y leptospira en la población de Jaltipan, Veracruz. Salud Publica Mex 2006; 48:220-228.

Cotto R, Avala A, Mosquera C, Russell K, Watt D. Seroprevalencia de dengue en la ciudad de Guayaquil y Durán, Ecuador, Abril 2000. Médicos-Ecuador 2000-2004 en línea: www.medicosecuador.com

Balsameda A, et al. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 2006; 2: 935-942.

Clyde K, Kyle J, Harris E. Minireview. Recente Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis. J Virol 2006: 11418-11431.

Kouri G. El Dengue, un problema creciente de salud en las Américas. Rev Panam Salud Pública 2006; 19:143-145.

Downloads

Published

2008-07-01

How to Cite

Dengue seroprevalence in Golfito and the central district of Puntarenas, Costa Rica 2005-2006. (2008). Acta Médica Costarricense , 50(3), 147-152. https://doi.org/10.51481/amc.v50i3.378